Terms: = Kidney tumors AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2
85 results:
1. [Robot-assisted left-side partial nephrectomy with a segmental resection of left lower ureter and Boari reconstruction].
Kurbanov AA; Kryukov SR; Chernov DV; Votyakov AY; Shpot EV
Urologiia; 2023 Sep; (4):125-128. PubMed ID: 37850292
[TBL] [Abstract] [Full Text] [Related]
2. Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma.
Gong M; Feng S; Zhou D; Luo J; Lin T; Qiu S; Yuan R; Dong W
Eur J Med Res; 2023 Oct; 28(1):440. PubMed ID: 37848987
[TBL] [Abstract] [Full Text] [Related]
3. Profiling of Serum miRNAs Constructs a Diagnostic 3-miRNA Panel for Clear-Cell Renal Cell Carcinoma.
Li X; Wen Z; Li R; Lu C; Chen W; Chen X; Huang G; Ni L; Lai Y; Tao L
Clin Genitourin Cancer; 2024 Feb; 22(1):23-32. PubMed ID: 37574436
[TBL] [Abstract] [Full Text] [Related]
4. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma.
Zeng K; Li Q; Song G; Chen B; Luo M; Miao J; Liu B
Cell Signal; 2023 Oct; 110():110838. PubMed ID: 37541641
[TBL] [Abstract] [Full Text] [Related]
5. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR; Ballas LK; Niemierko A; Lajkosz K; Kuk C; Miranda G; Drumm M; Mari A; Thio E; Fleshner NE; Kulkarni GS; Jewett MAS; Bristow RG; Catton C; Berlin A; Sridhar SS; Schuckman A; Feldman AS; Wszolek M; Dahl DM; Lee RJ; Saylor PJ; Michaelson MD; Miyamoto DT; Zietman A; Shipley W; Chung P; Daneshmand S; Efstathiou JA
Lancet Oncol; 2023 Jun; 24(6):669-681. PubMed ID: 37187202
[TBL] [Abstract] [Full Text] [Related]
6. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
7. Expression landscapes in non-small cell lung cancer shaped by the thyroid transcription factor 1.
Gloriane C Luna H; Severino Imasa M; Juat N; Hernandez KV; May Sayo T; Cristal-Luna G; Marie Asur-Galang S; Bellengan M; John Duga K; Brian Buenaobra B; De Los Santos MI; Medina D; Samo J; Minerva Literal V; Andrew Bascos N; Sy-Naval S
Lung Cancer; 2023 Feb; 176():121-131. PubMed ID: 36634573
[TBL] [Abstract] [Full Text] [Related]
8. Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor.
Yukihiro K; Teishima J; Goto K; Aoki G; Sekino Y; Hayashi T; Hasegawa Y; Mita K; Kato M; Kajiwara M; Shigeta M; Maruyama S; Kadonishi Y; Fujiwara S; Hinata N
Urol Oncol; 2022 Oct; 40(10):455.e11-455.e18. PubMed ID: 35851184
[TBL] [Abstract] [Full Text] [Related]
9. Revisiting immunological and clinical aspects of membranous nephropathy.
Nieto-Gañán I; Iturrieta-Zuazo I; Rita C; Carrasco-Sayalero Á
Clin Immunol; 2022 Apr; 237():108976. PubMed ID: 35276323
[TBL] [Abstract] [Full Text] [Related]
10. Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.
Zhou J; Singh P; Yin K; Wang J; Bao Y; Wu M; Pathak K; McKinley SK; Braun D; Lubitz CC; Hughes KS
Ann Surg Oncol; 2021 Oct; 28(11):6590-6600. PubMed ID: 33660127
[TBL] [Abstract] [Full Text] [Related]
11. Description of multimorbidity clusters of admitted patients in medical departments of a general hospital.
Matesanz-Fernández M; Seoane-Pillado T; Iñiguez-Vázquez I; Suárez-Gil R; Pértega-Díaz S; Casariego-Vales E
Postgrad Med J; 2022 Apr; 98(1158):294-299. PubMed ID: 33547138
[TBL] [Abstract] [Full Text] [Related]
12. Enhancing disease awareness for tuberous sclerosis complex in patients with radiologic diagnosis of renal angiomyolipoma: an observational study.
Bausch K; Wetterauer C; Diethelm J; Ebbing J; Boll DT; Dill P; Rentsch CA; Seifert HH
BMC Nephrol; 2021 Jan; 22(1):47. PubMed ID: 33517888
[TBL] [Abstract] [Full Text] [Related]
13. The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy.
Lai Y; Tang F; Huang Y; He C; Chen C; Zhao J; Wu W; He Z
J Cell Physiol; 2021 Mar; 236(3):1616-1627. PubMed ID: 32783202
[TBL] [Abstract] [Full Text] [Related]
14. The induction of AMPK-dependent autophagy leads to P53 degradation and affects cell growth and migration in kidney cancer cells.
Patergnani S; Guzzo S; Mangolini A; dell'Atti L; Pinton P; Aguiari G
Exp Cell Res; 2020 Oct; 395(1):112190. PubMed ID: 32717219
[TBL] [Abstract] [Full Text] [Related]
15. [Hemoglobin drop after thrombolytic therapy in a 57-year-old stroke patient with "erosive gastritis"].
Vogel Y; Schulte-Fischedick A; Bauer H; Zobel C; Zienkiewicz T; Pinsdorf T
Internist (Berl); 2020 Jul; 61(7):746-753. PubMed ID: 32533196
[TBL] [Abstract] [Full Text] [Related]
16. [Surgical treatment of intracaval tumor relapse after radical tumor nephrectomy in locally advanced renal cell carcinoma].
von Zehmen T; Eich C; Fries J; von Brandenstein M; Pfister D; Heidenreich A
Urologe A; 2020 Oct; 59(10):1217-1224. PubMed ID: 32514706
[TBL] [Abstract] [Full Text] [Related]
17. Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies.
Lee AHS; Hodi Z; Soomro I; Sovani V; Abbas A; Rakha E; Ellis IO
Histopathology; 2020 Aug; 77(2):303-313. PubMed ID: 32396659
[TBL] [Abstract] [Full Text] [Related]
18. Various forms of HIF-1α protein characterize the clear cell renal cell carcinoma cell lines.
Swiatek M; Jancewicz I; Kluebsoongnoen J; Zub R; Maassen A; Kubala S; Udomkit A; Siedlecki JA; Sarnowski TJ; Sarnowska E
IUBMB Life; 2020 Jun; 72(6):1220-1232. PubMed ID: 32250548
[TBL] [Abstract] [Full Text] [Related]
19. Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer.
Hińcza K; Kowalik A; Kowalska A
Genes (Basel); 2019 Jun; 10(7):. PubMed ID: 31247975
[TBL] [Abstract] [Full Text] [Related]
20. Comparative Analysis of Blood Plasma Proteome in Patients with Renal Cell Carcinoma.
Kaysheva AL; Kopylov AT; Kushlinskii NE; Gershtein ES; Alferov AA; Morozov AA; Kazantseva IA; Pleshakova TO; Archakov AI; Ivanov YD
Bull Exp Biol Med; 2019 May; 167(1):91-96. PubMed ID: 31177467
[TBL] [Abstract] [Full Text] [Related]
[Next]
